Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis
- 1 November 2006
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 6 (1) , 37-41
- https://doi.org/10.1016/j.autrev.2006.03.008
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- A comparison of the diagnostic accuracy and prognostic value of the first and second anti-cyclic citrullinated peptides (CCP1 and CCP2) autoantibody tests for rheumatoid arthritisAnnals of the Rheumatic Diseases, 2005
- Use and significance of anti-CCP autoantibodies in rheumatoid arthritisRheumatology, 2005
- Anti-CCP Antibody Detection Facilitates Early Diagnosis and Prognosis of Rheumatoid ArthritisCurrent Rheumatology Reviews, 2005
- Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2004
- Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemiaArthritis & Rheumatism, 2004
- Autoantibodies to Citrullinated (Poly)Peptides: A Key Diagnostic and Prognostic Marker for Rheumatoid ArthritisAutoimmunity, 2004
- PAD, a growing family of citrullinating enzymes: genes, features and involvement in diseaseBioEssays, 2003
- How to diagnose rheumatoid arthritis early: A prediction model for persistent (erosive) arthritisArthritis & Rheumatism, 2002
- The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritisArthritis & Rheumatism, 2000
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988